Vid Leko

Vid Leko, M.D.

  • Center for Cancer Research
  • National Cancer Institute
Immune Deficiency Cellular Therapy Program


Dr. Leko is a Physician-Scientist Early Investigator whose research focuses on developing T cell-based therapies for patients suffering from myelodysplastic syndromes, acute myeloid leukemia and other cancers that are resistant to currently available therapies. 

Areas of Expertise

Tumor Immunology
Tumor Antigens
Adoptive Cell Transfer
Myelodysplastic Syndromes

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.


Selected Recent Publications

Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma

Leko V, Cafri G, Yossef R, Paria B, Hill V, Gurusamy D, Zheng Z, Gartner JJ, Prickett TD, Goff SL, Robbins P, Lu YC, Rosenberg SA.
J Immunother Cancer. 9(7): e002882, 2021. [ Journal Article ]

Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors

Leko V, Rosenberg SA.
Cancer Cell. 38(4): 454-472, 2020. [ Journal Article ]

Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer

Leko V, McDuffie LA, Zheng Z, Gartner JJ, Prickett TD, Apolo AB, Agarwal PK, Rosenberg SA, Lu YC.
J Immunol. 202(12): 3458-3467, 2019. [ Journal Article ]

Job Vacancies

There are no open positions at this time. Check back again later, or take a look at CCR's Careers page.


Learn more about CCR research advances, new discoveries and more on our news section.